BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19915359)

  • 1. [Progress in the molecular analysis of infant leukemias].
    Ishii E
    Rinsho Ketsueki; 2009 Oct; 50(10):1500-5. PubMed ID: 19915359
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of NG2 antigen in MLL-rearranged acute leukemias: how complex does it get?
    Menendez P; Bueno C
    Leuk Res; 2011 Aug; 35(8):989-90. PubMed ID: 21492935
    [No Abstract]   [Full Text] [Related]  

  • 3. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
    Kobayashi Y; Hayashi Y; Ozawa K; Asano S
    Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
    Jung R; Jacobs U; Krumbholz M; Langer T; Keller T; De Lorenzo P; Valsecchi MG; van der Velden VH; Moericke A; Stanulla M; Teigler-Schlegel A; Panzer-Gruemayer ER; van Dongen JJ; Schrappe M; den Boer ML; Pieters R; Rascher W; Metzler M
    Leukemia; 2010 Apr; 24(4):903-7. PubMed ID: 20164851
    [No Abstract]   [Full Text] [Related]  

  • 5. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.
    Alexander FE; Patheal SL; Biondi A; Brandalise S; Cabrera ME; Chan LC; Chen Z; Cimino G; Cordoba JC; Gu LJ; Hussein H; Ishii E; Kamel AM; Labra S; Magalhães IQ; Mizutani S; Petridou E; de Oliveira MP; Yuen P; Wiemels JL; Greaves MF
    Cancer Res; 2001 Mar; 61(6):2542-6. PubMed ID: 11289128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group.
    Pombo-de-Oliveira MS; Andrade FG;
    Arch Med Res; 2016 Nov; 47(8):593-606. PubMed ID: 28476187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
    Ishida H; Kanamitsu K; Washio K; Muraoka M; Sakakibara K; Matsubara T; Kanzaki H; Shimada A
    Pediatr Blood Cancer; 2016 Nov; 63(11):2059-60. PubMed ID: 27322816
    [No Abstract]   [Full Text] [Related]  

  • 8. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
    Kubicka M; Soszynska K; Mucha B; Rafinska B; Kolodziej B; Haus O; Styczynski J
    Leuk Lymphoma; 2007 Oct; 48(10):2083-6. PubMed ID: 17917979
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia.
    Millot F; Brizard F; Sorel N; Preudhomme C; Cividin M; Guilhot F; Brizard A
    Leuk Lymphoma; 2005 Jun; 46(6):925-7. PubMed ID: 16019540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach.
    Binato R; Meyer C; Macedo-Silva ML; Garcia D; Figueiredo A; Hofmann J; Vieira TP; Abdelhay E; Marschalek R
    Cancer Lett; 2013 Sep; 338(2):249-54. PubMed ID: 23562474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
    Mosad E; Abdou M; Zaky AH
    Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis.
    Patejdl R; Krohn S; Murua Escobar H; Zettl UK
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):413-4. PubMed ID: 25851557
    [No Abstract]   [Full Text] [Related]  

  • 13. Infant leukaemia biology, aetiology and treatment.
    Greaves MF
    Leukemia; 1996 Feb; 10(2):372-7. PubMed ID: 8637251
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM; Dolan M; Casey T; Perkins JL
    J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research.
    Pelkonen O; Terron A; Hernandez AF; Menendez P; Bennekou SH;
    Arch Toxicol; 2017 Aug; 91(8):2763-2780. PubMed ID: 28536863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II and the etiology of chromosomal translocations.
    Felix CA; Kolaris CP; Osheroff N
    DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of estrogen.
    Aljurf M; Saleh AJ; Ahmed SO
    Leuk Res; 2011 Jul; 35(7):e127. PubMed ID: 21396712
    [No Abstract]   [Full Text] [Related]  

  • 19. The MLL recombinome of acute leukemias in 2017.
    Meyer C; Burmeister T; Gröger D; Tsaur G; Fechina L; Renneville A; Sutton R; Venn NC; Emerenciano M; Pombo-de-Oliveira MS; Barbieri Blunck C; Almeida Lopes B; Zuna J; Trka J; Ballerini P; Lapillonne H; De Braekeleer M; Cazzaniga G; Corral Abascal L; van der Velden VHJ; Delabesse E; Park TS; Oh SH; Silva MLM; Lund-Aho T; Juvonen V; Moore AS; Heidenreich O; Vormoor J; Zerkalenkova E; Olshanskaya Y; Bueno C; Menendez P; Teigler-Schlegel A; Zur Stadt U; Lentes J; Göhring G; Kustanovich A; Aleinikova O; Schäfer BW; Kubetzko S; Madsen HO; Gruhn B; Duarte X; Gameiro P; Lippert E; Bidet A; Cayuela JM; Clappier E; Alonso CN; Zwaan CM; van den Heuvel-Eibrink MM; Izraeli S; Trakhtenbrot L; Archer P; Hancock J; Möricke A; Alten J; Schrappe M; Stanulla M; Strehl S; Attarbaschi A; Dworzak M; Haas OA; Panzer-Grümayer R; Sedék L; Szczepański T; Caye A; Suarez L; Cavé H; Marschalek R
    Leukemia; 2018 Feb; 32(2):273-284. PubMed ID: 28701730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the use of NG2 antigen as a marker to predict MLL rearrangements in multi-center studies.
    Emerenciano M; Renaud G; Sant'Ana M; Barbieri C; Passetti F; Pombo-de-Oliveira MS;
    Leuk Res; 2011 Aug; 35(8):1001-7. PubMed ID: 21444110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.